BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17972252)

  • 1. Why is PTEN an important tumor suppressor?
    Li L; Ross AH
    J Cell Biochem; 2007 Dec; 102(6):1368-74. PubMed ID: 17972252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN, more than the AKT pathway.
    Blanco-Aparicio C; Renner O; Leal JF; Carnero A
    Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN: a new guardian of the genome.
    Yin Y; Shen WH
    Oncogene; 2008 Sep; 27(41):5443-53. PubMed ID: 18794879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions and regulation of the PTEN tumour suppressor.
    Song MS; Salmena L; Pandolfi PP
    Nat Rev Mol Cell Biol; 2012 Apr; 13(5):283-96. PubMed ID: 22473468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.
    Hopkins BD; Parsons RE
    Clin Cancer Res; 2014 Nov; 20(21):5379-83. PubMed ID: 25361917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN mutation: many birds with one stone in tumorigenesis.
    Liu W; Zhou Y; Reske SN; Shen C
    Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.
    Li L; Dutra A; Pak E; Labrie JE; Gerstein RM; Pandolfi PP; Recht LD; Ross AH
    Neuro Oncol; 2009 Feb; 11(1):9-21. PubMed ID: 18812521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
    Cully M; You H; Levine AJ; Mak TW
    Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PTEN using small molecule inhibitors.
    Mak LH; Woscholski R
    Methods; 2015 May; 77-78():63-8. PubMed ID: 25747336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
    Heering J; Erlmann P; Olayioye MA
    Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor suppressor PTEN in tumor necrosis factor alpha-induced inhibition of insulin signaling in murine skeletal muscle C2C12 cells.
    Lo YT; Tzeng TF; Liu IM
    Horm Metab Res; 2007 Mar; 39(3):173-8. PubMed ID: 17373630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PTEN promotes tumor development in malignant melanoma.
    Stahl JM; Cheung M; Sharma A; Trivedi NR; Shanmugam S; Robertson GP
    Cancer Res; 2003 Jun; 63(11):2881-90. PubMed ID: 12782594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity and acute regulation of the tumour suppressor phosphatase, PTEN.
    Downes CP; Perera N; Ross S; Leslie NR
    Biochem Soc Symp; 2007; (74):69-80. PubMed ID: 17233581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal PTEN expression in portal hypertensive gastric mucosa: a key to impaired PI 3-kinase/Akt activation and delayed injury healing?
    Tsugawa K; Jones MK; Akahoshi T; Moon WS; Maehara Y; Hashizume M; Sarfeh IJ; Tarnawski AS
    FASEB J; 2003 Dec; 17(15):2316-8. PubMed ID: 14525948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PTEN/PI3K pathway in endothelial cells.
    Suzuki A; Hamada K; Sasaki T; Mak TW; Nakano T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):172-6. PubMed ID: 17371230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
    Cheng LM; Wang SY; Lin JS
    Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.